Keraceuticals

Keraceuticals is a biotechnology company specializing in the development of keratin-based regenerative therapies for dermatology and hair care. Originating from research conducted at the Wake Forest Institute for Regenerative Medicine, the company utilizes a proprietary extraction process to produce highly purified keratin proteins. These proteins serve as functional scaffolds that promote cell proliferation and tissue regeneration, particularly in the context of hair follicle restoration and wound healing. The company's portfolio targets significant unmet needs in dermatology, including alopecia and chronic wound management. By leveraging the natural biological properties of keratin, Keraceuticals aims to deliver innovative, biocompatible solutions for tissue repair.